Amgen Inc. buy The Goldman Sachs Group, Inc.
Start price
04.02.26
/
50%
€282.50
Target price
04.02.27
€350.97
Performance (%)
29.57%
Price
18:48
€361.00
Summary
This prediction is currently active. The prediction currently has a performance of 29.57%. Dividends of €5.04 are taken into consideration when calculating the performance. This prediction currently runs until 04.02.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 0.999% | 0.999% |
| iShares Core DAX® | 0,44 % | 5,90 % |
| iShares Nasdaq 100 | 1,06 % | 0,92 % |
| iShares Nikkei 225® | 1,77 % | 1,23 % |
| iShares S&P 500 | 0,37 % | 1,92 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $403.00 to $415.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat